QW 7437

Drug Profile

QW 7437

Alternative Names: QW7437; SonoGen

Latest Information Update: 04 Apr 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sonus Pharmaceuticals
  • Class Contrast media; Fluorocarbons
  • Mechanism of Action Ultrasonography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Myocardial infarction

Most Recent Events

  • 04 Apr 2008 Discontinued - Phase-I for Myocardial infarction (diagnosis) in USA (Parenteral)
  • 15 Mar 2000 Phase I clinical trials have been completed
  • 18 Jun 1999 Phase-I clinical trials for Myocardial infarction (diagnosis) in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top